Subscribe To Our Free Newsletter |
Biocon’s Andhra Pradesh facility gets 3 USFDA observations
Biocon said that US Food and Drug Administration (USFDA) issued three observations after the good manufacturing practices (GMP) inspection conducted at its API manufacturing facility situated at Visakhapatnam, Andhra Pradesh.